About Cardiovascular Diabetology

What is Cardiovascular Diabetology?

Cardiovascular Diabetology is an open access, peer-reviewed, online journal that considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome; this includes genetic, experimental, clinical, pharmacological, epidemiological, molecular biology and laboratory research.

Cardiovascular Diabetology aims to provide an address for all types of scientific communications related to the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome. The impressive correlation between coronary artery disease and alterations in glucose metabolism has raised the likelihood that atherosclerosis and type 2 diabetes may share common antecedents. Large-vessel atherosclerosis can precede the development of diabetes, suggesting that rather than atherosclerosis being a complication of diabetes, both conditions may share genetic and environmental antecedents, a "common soil". Insulin resistance and hyperinsulinemia lead to the development of the dysmetabolic syndrome, consisting of abdominal obesity, impaired fasting glucose, high triglyceride levels, low high-density lipoprotein levels and hypertension. Taking into consideration that this cluster of abnormalities is shared by both diabetes type 2 and atherosclerosis, the American Heart Association stated in 1999 that "diabetes is a cardiovascular disease".

The worldwide prevalence of the dysmetabolic syndrome and diabetes mellitus - especially type 2, which makes up about 90% of the diabetic population - has continuously and rapidly increased during the last decades. The number of diabetic individuals is to double within 30 years, reaching 300 million in the year 2025. Premature atherosclerosis contributes to 75% of deaths among individuals with both type 1 and type 2 diabetes. Moreover, 25% of patients with newly diagnosed type 2 diabetes already have coronary artery disease. Diabetes mellitus has become a diagnosis of considerable and ominous importance in cardiovascular medicine, related to numerous hospital readmissions and high mortality and morbidity. Despite considerable improvements in the treatment of cardiovascular diseases, there is alarming evidence that patients with diabetes have hardly experienced any advantages from recent therapeutic achievements compared with their non-diabetic counterparts. Thus, a journal specifically dedicated to these issues is essential.

Translations

The open access journal Archivos de Medicina offers authors whose papers have been accepted for publication in Cardiovascular Diabetology the option of publishing a Spanish translation of their article. Further details can be found here.

Content overview

Cardiovascular Diabetology considers the following types of articles:

• Original Investigation - Original articles should contain previously unpublished data with clear experimental or clinical relevance.
• Case reports - Articles that 1. can be used for educational purposes, as a necessary reminder of an important clinical lesson, or that describe a diagnostic or therapeutic dilemma; 2. suggest the need for change in practice or thinking in terms of diagnosis or prognosis, but not in terms of preventive or therapeutic intervention, which require stronger evidence; 3. suggest an association between two conditions; or 4. present an important adverse reaction to treatment.
• Commentaries - These short, narrowly focused articles of contemporary interest are usually commissioned by the journal. They are not minireviews. A Commentary is usually a discussion of an article or trial that was recently published or that is soon to be published, and that is interesting enough to warrant further comment or explanation. This type of Commentary discusses specific issues within a subject area rather than the whole field, explains the implications of the article and put it in context. Opinions are welcome as long as they are factually based.
• Hypotheses - These articles should present an untested original hypothesis backed up solely by a survey of previously published results rather than any new evidence. Hypotheses should not be reviews and should not contain new data. They should ideally be short articles (maximum 1500 words) outlining significant progress in thinking that would also be testable, though not so easily testable that readers will wonder why the testing has not already been done.
• Methodology articles - These articles should present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
• Reviews - Summaries of recent insights in specific research areas within the scope of Cardiovascular Diabetology. They can be submitted either upon specific invitation or editorial acceptance of an author's proposal. To submit a proposal, authors should send a tentative title and abstract to the Editorial Office and justify their expertise in the target area, and also both the scientific relevance and the lack of recent reviews on the topic
• Study protocols - Describe proposed or ongoing research, providing a detailed account of the hypothesis, rationale, and methodology of the study. Authors of protocols or reports of controlled trials of health care interventions must register their trial prior to submission in a suitable publicly accessible registry.

Peer review policies

Peer review in Cardiovascular Diabetology is designed to ensure that the research published is 'good science'. Cardiovascular Diabetology considers manuscripts spanning a wide range of scientific interests, as long as the results and conclusions are scientifically justified and not misleading. In deciding whether to accept or reject a manuscript, a reviewer asks him/herself whether the scientific community is better served by publishing or not publishing the manuscript. The suitability of a research article for publication in Cardiovascular Diabetology is assessed by peer reviewers, who base their decision primarily on the article's validity and coherence but who also consider its comprehensibility and level of interest to the reader.

Edited by Enrique Z. Fisman and Alexander Tenenbaum, Cardiovascular Diabetology is supported by an expert Editorial Board.

Publishing in Cardiovascular Diabetology

All articles are listed in PubMed immediately upon acceptance (after peer review), and are covered by PubMed Central, MEDLINE, Thomson Reuters (ISI), CAS, Embase and Current Contents.

Articles in Cardiovascular Diabetology should be cited in the same way as articles in a traditional journal. However, because articles in this journal are not printed, they do not have page numbers. Instead, they have a unique article number.

The following citation:

Cardiovasc Diabetol 2004, 2:1

refers to article 1 from volume 2 of the journal.

As an online journal, Cardiovascular Diabetology does not have issue numbers. Each volume corresponds to a calendar year.

To keep up to date with the latest articles from Cardiovascular Diabetology, why not register to receive alerts? Registration also enables you to customise your subject areas of interest, store your searches, and submit your manuscripts.

Submission of manuscripts

Manuscripts should be submitted electronically to Cardiovascular Diabetology using the online submission system. Full details of how to submit a manuscript are given in the instructions for authors.

General journal policies

Cardiovascular Diabetology is published by BioMed Central, part of Springer Science+Business Media. BioMed Central is committed to ensuring peer-reviewed biomedical research is open access. That means it is freely and universally accessible online, it is archived in at least one internationally recognised free access repository, and its authors retain copyright, allowing anyone to reproduce or disseminate articles, according to the BioMed Central copyright and licence agreement. Cardiovascular Diabetology however, has taken this further by making all its content open access.

Cardiovascular Diabetology's articles are archived in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and also at INIST in France and in e-Depot, the National Library of the Netherlands' digital archive of all electronic publications. The journal is also participating in the British Library's e-journals pilot project, and plans to deposit copies of all articles with the British Library.

BioMed Central is working closely with Thomson Reuters (ISI) to ensure that citation analysis of articles published in Cardiovascular Diabetology will be available.

Cardiovascular Diabetology is able to deliver summaries of frequently updated content via Really Simple Syndication (RSS) feeds. These are accessible via the orange "XML" button at the top of the list of recent articles or the list of most accessed articles. For more information about RSS feeds see our publisher's website.

For further information about general policies please see the instructions for authors.